TY  - GEN
AU  - López-Sainz, Ángela
AU  - Hernandez-Hernandez, Aitor
AU  - Gonzalez-Lopez, Esther
AU  - Domínguez, Fernando
AU  - Restrepo-Cordoba, Maria Alejandra
AU  - Cobo-Marcos, Marta
AU  - Gómez-Bueno, Manuel
AU  - Hernandez-Perez, Francisco Jose
AU  - Oteo, Juan Francisco
AU  - Mirelis, Jesus G
AU  - Cavero, Miguel Angel
AU  - Moñivas, Vanessa
AU  - Mingo Santos, Susana
AU  - de Haro-Del Moral, F Javier
AU  - Krsnik, Isabel
AU  - Salas, Clara
AU  - Bornstein, Belén
AU  - Briceño, Ana
AU  - López, Juan Antonio
AU  - Vázquez, Jesús
AU  - Alonso-Pulpón, Luis
AU  - Segovia, Javier
AU  - Garcia-Pavia, Pablo
PY  - 2021
UR  - https://hdl.handle.net/20.500.12105/27587
AB  - Cardiac amyloidosis (CA) is produced by amyloid fiber deposition in the myocardium. The most frequent forms are those caused by light chains (AL) and transthyretin (ATTR). Our objective was to describe the diagnosis, treatment and outcomes of CA in a...
LA  - eng
PB  - EDICIONES DOYMA
KW  - Amiloidosis cardiaca
KW  - Amiloidosis por cadenas ligeras
KW  - Amiloidosis por transtiretina
KW  - Amyloid light-chain amyloidosis
KW  - Cardiac amyloidosis
KW  - Prognosis
KW  - Pronóstico
KW  - Transthyretin
KW  - Transthyretin amyloidosis
KW  - Transtiretina
KW  - Tratamiento
KW  - Treatment
TI  - Clinical profile and outcome of cardiac amyloidosis in a Spanish referral center.
TY  - research article
ER  -